TORONTO, ONTARIO--(Marketwired - Oct 4, 2017) - Spectral Medical Inc., (EDT.TO), a Phase III company developing the first treatment for patients with endotoxemic septic shock, announced that, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results